Blog

Early Phase Oncology Trial Designs: Model-Based Approach

Clinical

Early Phase Oncology Trial Designs: Model-Based Approach

Early Phase Oncology Trial Designs: The Model-Assisted Approach

Clinical

Early Phase Oncology Trial Designs: The Model-Assisted Approach

Butyrate production by Bifidobacterium bifidum

Microbiome Monday

Butyrate production by Bifidobacterium bifidum

L.helveticus: A lactobacilli for cancer treatment

Microbiome Monday

L.helveticus: A lactobacilli for cancer treatment

Probiotics in focus: How does L. reuteri affect gut health?

Microbiome Monday

Probiotics in focus: How does L. reuteri affect gut health?

CAR T-cell Therapy Program Development: Key Considerations

Preclinical

CAR T-cell Therapy Program Development: Key Considerations

Efficient Data Management: One Way to Expedite the Clinical Development Process

Clinical

Efficient Data Management: One Way to Expedite the Clinical Development Process

 

Clinical

The Clinical Trial Process Continues Amid COVID-19

 

Clinical

Technology Challenges and Trends in Clinical Trials

 

Preclinical

Maximizing Reproducibility in Cancer Research

 

Preclinical

Will Your Cancer Drug Move Past Phase 1?

 

Preclinical

The Missing Step Between Phase I and Phase II

 

Preclinical

Now Available: Liver Fibrosis Models Fed Choline-Deficient, High-Fat Diets

 

Preclinical

The Keto Diet and Cancer Research: New Insights Emerge

 

PK/ADME

Early DMPK Analysis Means Opportunity for Better Results

 

Preclinical

In Vitro vs. In Vivo Preclinical Drug Testing

 

Regulatory

Oncology Drug Approval Process

 

Preclinical

Future Trends for Oncology Drug Development

 

Clinical

The Top 5 Challenges in Oncology Drug Development

 

Clinical

Move your research forward, smarter with TD2

 

Clinical

Your Guide to a Smart Clinical Strategy

 

Preclinical

Research Review: 4 Secrets for Preclinical Success

 

Regulatory

What is the Difference Between Research and Commercial IND Categories?

 

Regulatory

What are the Types of INDs?